Inhibition of cytokine response by methylprednisolone attenuates antithrombin reduction following hepatic resection [2]

Thrombosis and Haemostasis

Volumn 93, Issue 6, 2005, Pages 1199-1200

  Pulitanò, Carlo ^a   Aldrighetti, Luca ^a   Finazzi, Renato ^a   Arru, Marcella ^a   Catena, Marco ^a   Ferla, Gianfranco ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTITHROMBIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CYTOKINE; INTERLEUKIN 6; METHYLPREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANALYSIS OF VARIANCE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG MECHANISM; DRUG PULSE THERAPY; HUMAN; LETTER; LIVER ISCHEMIA; LIVER RESECTION; PARTIAL THROMBOPLASTIN TIME; PATIENT MONITORING; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY; BIOSYNTHESIS; INJURY; LIVER; METABOLISM; PATHOPHYSIOLOGY; VASCULARIZATION;

ANTITHROMBINS; CYTOKINES; HUMANS; INTERLEUKIN-6; LIVER; METHYLPREDNISOLONE; PROSPECTIVE STUDIES; REPERFUSION INJURY;

EID: 20444462737     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/th06-01-0058     Document Type: Letter

References (15)

1. Teoh N, Farrell GC. Hepatic ischemia reperfusion injury. Pathogenic mechanism and basis for Hepatoprotection. J Gastroenterol Hepatol 2003; 18: 891-902.
2. Kragsbjerg P, Holmberg H, Vikerfors T. Serum concentrations of Interleukin-6, Tumor Necrosis Factor-a, and C-reactive Protein in Patients Undergoing Major Operations. Eur J Surg 1995; 161: 17-22.
3. Patel RT, Deen KI, Youngs D et al. Interleukin-6 is a prognostic indicator of outcome in severe intra-abdominal sepsis. Br J Surg 1994; 81: 1306-8.
4. Biffi Wl, Moore EE, Moore FA et al. Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation ? Ann Surg 1996; 224: 647-64.
5. Tsuji K, Eguchi y, Kodama M. Postoperative hypercoagulable state followed by hyperfibrinolysis related to wound healing after hepatic resection. J Am Coll Surg 1996; 183: 230-8.
6. Sinischalchi A, Begliomini B, De Pietri L et al. Increased prothrombin time and platelet counts in living donor right hepatectomy: implications for epidural anesthesia. Liver Transpl 2004; 10: 1144-9.
7. Rosenberg RD. Biochemistry of heparin antithrombin interactions, and the physiologic role of this natural anticoagulant mechanism. Am J Med 1989; 87: 2S-9S.
8. Wilson R, Mammen E, Robson M et al. Antithrombin, prekalikrein, and fibronectn levels in surgical patients. Arch. Surg 1986; 121: 635-40.
9. Hashimoto K, Yamagishi M, Sasaki T et al. Heparin and antithrombin III levels during cardiopulmonary bypass: Correlation with subclinical plasma coagulation. Ann Thorac Surg 1994; 58: 804-5.
10. Roemisch J, Gray E, Hoffmann JN et al. Antithrombin: a new look at the actions of a serine protease inhibitor. 2002; 13: 657-70.
11. Harada N, Okajima K, Uchiba M et al. Antithrombin reduces ischemia/reperfusion-induced liver injury in rats by activation of cyclooxygenase-1. Thromb, Haemost 2004; 92: 550-8.
12. Shimada M, Matsumata T, Kamakura T et al. Modulation of coagulation and fibrinolysis in hepatic resection: A randomized prospective control study using antithrombin III concentrates. Thromb Res 1994; 74: 105-14.
13. Muratore A, Ribero D, Ferrero A et al. Prospective randomized study of steroids in the prevention of ischaemic injury durino hepatic resection with pedicle camping. Br J Surg 2003; 90: 17-22.
14. Stouthard JM, Levi M, Hack CE et al. Interleukin-6 stimulates coagulation, not fibrinolysis, in humans. Thromb Haemost 1996; 76: 738-42.
15. Matsutani T, Onda M, Sasajima K et al. Glucocorticoid attenuates a decrease of antithrombin III following major surgery. J Surg Res 1998; 79: 158-63.